Announced Mon, 28 Sept, 2026 · 12:17 IST
Trading window closed for half yearly results
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+4.0%1-day move
₹347.00
prior close
₹353.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+4.0+6.1+4.0+6.3+4.0+15.7————
Up moveDown movePending
AI summary
Aptus Pharma has closed its trading window from October 1, 2026 until 48 hours after the declaration of its half yearly financial results for the period ending September 30, 2026. This is a routine compliance step under the company's Insider Trading Code, signed by Managing Director Tejash Hathi. During the closed period, designated insiders are barred from trading the company's shares.
Likely market impact
Insiders cannot trade shares until half yearly results are declared plus 48 hours. Signals upcoming results announcement.